Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Jan 21;11(2):225–238. doi: 10.1080/15548627.2014.998931

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2015 Taylor & Francis Group, LLC

PMC Copyright notice

Figure 2. — Immunohistochemistry of TXNDC17 and BECN1 expression and patient prognosis and survival analysis. (A) Two serial sections from the same paraffin-embedded block from 157 ovarian cancer patients were used for detection using anti-TXNDC17 and anti-BECN1 antibodies, respectively. Representative TXNDC17 and BECN1 staining from a chemoresistant (4+) and a chemosensitive (1+) tissue is shown at 200× and 400× magnifications. (B) Kaplan–Meier survival curves for PFS and OS in ovarian cancer patients with different TXNDC17 and BECN1 protein levels. HR and 95% CI were measured by univariate Cox regression analysis. (C) Combined analysis of TXNDC17 and BECN1 expression in the prognostic value of patients with ovarian cancer by Kaplan–Meier survival curves. *, TXNDC17^high/BECN1^high VS TXNDC17^low/BECN1^low.